Хлебные крошки
- Главная
-
Аналитика
-
Акции
Акции внутренные
Arena Pharmaceuticals, Inc. ARNA
$99.99
На 18:00, 12 мая 2023
-5.99%
Потенциал через год
Ранг: 3
Ключевые показатели
-
Marketcap
0.00000000
-
week52high
100.00
-
week52low
45.50
-
Revenue
54000
-
P/E TTM
-9
-
Beta
0.54872000
-
EPS
-10.14300000
-
Last Dividend
0.00000000
-
Next Earnings Date
04 мая 2022 г. в 04:00
Описание компании
Arena Pharmaceuticals, Inc., a biopharmaceutical company, focuses on providing novel medicines with pharmacology and pharmacokinetics to patients worldwide. The company's investigational clinical programs include Etrasimod (APD334) that is in Phase III clinical trial for ulcerative colitis, Phase IIb/III clinical trial for Crohn's disease, Phase II clinical trial for alopecia areata, Phase III clinical trial for atopic dermatitis, and Phase IIb clinical trial for eosinophilic esophagitis; Olorinab (APD371), which is in Phase IIb clinical trial for the treatment of abdominal pain associated with irritable bowel syndrome; APD418 that is in Phase II clinical trial for acute heart failure; and Temanogrel for coronary microvascular obstruction that is in Phase II clinical trial. It also develops ralinepag (APD811), which is in Phase III clinical trial for pulmonary arterial hypertension. The company has collaboration agreements with United Therapeutics Corporation; Everest Medicines Limited; Eisai Co., Ltd. and Eisai Inc.; Boehringer Ingelheim International GmbH; Beacon Discovery, Inc.; and Aristea Therapeutics, Inc. Arena Pharmaceuticals, Inc. was incorporated in 1997 and is based in Park City, Utah. As of March 11, 2022, Arena Pharmaceuticals, Inc. operates as a subsidiary of Pfizer Inc.
Рекомендации
аналитиков
Рекомендации аналитиков
| Grading company | New grade | Previous grade | Recommendation date |
|---|---|---|---|
| HC Wainwright & Co. | Neutral | Buy | 09 февр 2022 г. |
| Cantor Fitzgerald | Neutral | Overweight | 21 дек 2021 г. |
| SVB Leerink | Market Perform | Outperform | 14 дек 2021 г. |
| RBC Capital | Sector Perform | Outperform | 14 дек 2021 г. |
| JMP Securities | Market Perform | Market Outperform | 14 дек 2021 г. |
Оставьте свой голос
Оставьте свой голос
Анонимное голосование
Будет ли рост российского рынка к концу года?
-
Да
87% -
Нет
12%
Проголосовал 8 человек
Покожие компании
Insider Summary
Insider Summary
| Reporting Name | Acquistion/Disposition | Owned | Transacted | Transaction Date |
|---|---|---|---|---|
| Ouzren Nawal | D | 0 | 7202 | 11 мар 2022 г. |
| Ouzren Nawal | D | 0 | 3665 | 11 мар 2022 г. |
| Ouzren Nawal | D | 3665 | 890 | 11 мар 2022 г. |
| Dallas Jayson Donald Alexander | D | 0 | 7202 | 11 мар 2022 г. |
| Dallas Jayson Donald Alexander | D | 0 | 3067 | 11 мар 2022 г. |
| Dallas Jayson Donald Alexander | D | 3067 | 4085 | 11 мар 2022 г. |
| Schoch Steven J | D | 0 | 7202 | 11 мар 2022 г. |
| Schoch Steven J | D | 0 | 4600 | 11 мар 2022 г. |
| NEIL GARRY ARTHUR | D | 0 | 7202 | 11 мар 2022 г. |
| NEIL GARRY ARTHUR | D | 0 | 3067 | 11 мар 2022 г. |
Institutional Ownership
Institutional Ownership
| Holder | Shares | Change | Date Reported |
|---|---|---|---|
| DIMENSIONAL FUND ADVISORS LP | 773286 | -20240 | 31 дек 2021 г. |
| Vanguard Total Stock Market Index Fund | 1575880 | -25265 | 31 авг 2020 г. |
| iShares Russell 2000 ETF | 1209470 | 34656 | 31 авг 2020 г. |
| SPDR S&P Biotech ETF | 904829 | -46556 | 31 авг 2020 г. |
| Vanguard Small-Cap Index Fund | 1387040 | -11460 | 31 июл 2020 г. |
| Vanguard Small-Cap Growth Index Fund | 842896 | -5412 | 31 июл 2020 г. |
| Vanguard Extended Market Index Fund | 791837 | -1610 | 31 июл 2020 г. |
| Lord Abbett Securities Trust - Growth Leaders Fund | 660826 | 11237 | 31 июл 2020 г. |
| Fidelity Select Biotechnology Portfolio | 621373 | -229900 | 31 июл 2020 г. |
| Stichting Pensioenfonds ABP | 577710 | -88671 | 31 мар 2020 г. |
Свежие комментарии
Свежие комментарии